Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel multikinase inhibitor is active in FLT3-dependent leukemia cells

May 7, 2012

BRISK PS trial compares brivanib to placebo in liver cancer

May 7, 2012

Abbott designs novel focal adhesion kinase 1 inhibitors

May 7, 2012

Otsuka Pharmaceutical reports new candidate cancer therapies

May 7, 2012

Lead Sunesis product receives European orphan drug status

May 4, 2012

Idera Pharmaceuticals reports topline phase II IMO-2055 data

May 4, 2012

St. Jude Children's Research Hospital presents new Mdm2/Mdm4 antagonists

May 4, 2012

Genomic Health and OncoMed form alliance

May 3, 2012

Cleveland BioLabs and Incuron receive clearance for CBLC-137 trial in Russia

May 3, 2012

AVEO reports preliminary data from phase II ficlatuzumab combination trial

May 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...